Cronos Group

Cronos Group EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Cronos Group (CRON.TO) as of Oct 27, 2026 is -54.18. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -12.64 — a change of 328.59% (lower).

EV/EBIT

-54.18

YoY

328.59%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Cronos Group is 2025 -54.18 . EV/EBIT (Enterprise Value to EBIT) of Cronos Group was 2024 -12.64 . It decreases by 328.59% lower compared to the previous year.

The Cronos Group EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
-8.61 USD
Jan 1, 2020
-4.42 USD
Jan 1, 2021
-3.34 USD
Jan 1, 2022
-8.60 USD
Jan 1, 2023
-11.42 USD
Jan 1, 2024
-12.64 USD
Jan 1, 2025
-54.18 USD
Jan 1, 2026 (e)
20.20 USD
The Cronos Group EV/EBIT history
YEAREV/EBITYoY
est20.20-137.28%
-54.18+328.59%
-12.64+10.65%
-11.42+32.91%
-8.60+157.51%
-3.34-24.47%
-4.42-48.65%
-8.61-80.33%
-43.76-72.61%
-159.74-68.25%
-503.11-121.04%
2,391.24-781.29%
-350.99—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cronos Group Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Cronos Group's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Cronos Group's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Cronos Group's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Cronos Group grows earnings faster than its peers.

Cronos Group Stock analysis

What does Cronos Group do? Cronos Group Inc is a Canadian company specializing in the production and distribution of medical and recreational cannabis. It was founded in 2013 and is headquartered in Toronto, Canada. Cronos Group Inc is one of the leading cannabis producers in Canada and has also made a name for itself in the international market. History Cronos Group Inc started as a medical cannabis startup focused on the cultivation and production of high-quality cannabis products for the medical market. In 2016, the company was listed on the Toronto Stock Exchange and raised 40 million Canadian dollars through a capital increase. In 2018, it received a $1.8 billion investment from Altria Group Inc, one of the world's largest tobacco companies. This investment helped Cronos grow and establish itself in the global cannabis market. Business model Cronos Group Inc has a diversified business model focusing on the production, processing, and marketing of cannabis products. The company specializes in the cultivation and production of high-quality cannabis products suitable for both the medical and recreational markets. Cronos Group Inc also produces cannabis oils, vaporizer pens, and other smoke-free products. The various subsidiaries Cronos Group Inc consists of several subsidiary companies focusing on different aspects of the cannabis industry. Some of the key subsidiaries of Cronos Group Inc are: 1. Peace Naturals - This company specializes in the cultivation of medical cannabis and also produces cannabis oils and vaporizable products. 2. Original BC - Original BC is a leading provider of recreational cannabis, offering a wide range of cannabis products. 3. Sublime Culture - Sublime Culture specializes in the production of cannabis extracts and the development of novel cannabis products like THC-infused gummy bears. Products Cronos Group Inc offers a wide range of cannabis products suitable for both the medical and recreational markets. Some of the key products of Cronos Group Inc include: 1. Cannabis oils - The company produces a wide range of cannabis oils suitable for medical and recreational use. 2. Vaporizer pens - Cronos Group Inc also produces vaporizable products for smoke-free consumption of cannabis products. 3. Edibles - The company also offers a range of novel cannabis products like THC-infused gummy bears, contributing to the growth of the market. Conclusion Cronos Group Inc is one of the leading cannabis companies worldwide specializing in the production and distribution of medical and recreational cannabis. The company has made a name for itself with its wide range of cannabis products and has grown and established itself in the international market through the investment from Altria Group Inc. Cronos Group Inc has implemented a diversified business model, offering medical cannabis, recreational cannabis, and novel cannabis products to grow in the increasing demand and provide its customers with a wide range of offerings. Cronos Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cronos Group stock

EV/EBIT (Enterprise Value to EBIT) of Cronos Group is -54.18 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Cronos Group changed from -12.64 to -54.18, representing a 328.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Cronos Group since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Cronos Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cronos Group

All Key Metrics — Cronos Group